Your browser doesn't support javascript.
loading
Phase 1/2 trial of ixazomib, cyclophosphamide and dexamethasone in patients with previously untreated symptomatic multiple myeloma.
Kumar, Shaji K; Buadi, Francis K; LaPlant, Betsy; Halvorson, Alese; Leung, Nelson; Kapoor, Prashant; Dingli, David; Gertz, Morie A; Go, Ronald S; Bergsagel, P Leif; Lin, Yi; Dispenzieri, Angela; Hwa, Yi Lisa; Fonder, Amie; Hobbs, Miriam; Fonseca, Rafael; Hayman, Suzanne R; Stewart, A Keith; Lust, John A; Mikhael, Joseph; Gonsalves, Wilson; Reeder, Craig; Skacel, Tomas; Rajkumar, S Vincent; Lacy, Martha Q.
Affiliation
  • Kumar SK; Division of Hematology, Mayo Clinic, Rochester, MN, USA. kumar.shaji@mayo.edu.
  • Buadi FK; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
  • LaPlant B; Department of Biostatistics, Mayo Clinic, Rochester, MN, USA.
  • Halvorson A; Department of Biostatistics, Mayo Clinic, Rochester, MN, USA.
  • Leung N; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
  • Kapoor P; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
  • Dingli D; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
  • Gertz MA; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
  • Go RS; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
  • Bergsagel PL; Division of Hematology and Oncology, Mayo Clinic, Phoenix, AZ, USA.
  • Lin Y; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
  • Dispenzieri A; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
  • Hwa YL; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
  • Fonder A; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
  • Hobbs M; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
  • Fonseca R; Division of Hematology and Oncology, Mayo Clinic, Phoenix, AZ, USA.
  • Hayman SR; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
  • Stewart AK; Division of Hematology and Oncology, Mayo Clinic, Phoenix, AZ, USA.
  • Lust JA; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
  • Mikhael J; Division of Hematology and Oncology, Mayo Clinic, Phoenix, AZ, USA.
  • Gonsalves W; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
  • Reeder C; Division of Hematology and Oncology, Mayo Clinic, Phoenix, AZ, USA.
  • Skacel T; Takeda Pharmaceutical Company Limited, Osaka, Japan.
  • Rajkumar SV; 31st Medical Department Clinical Department of Haematology of the First Faculty of Medicine and General, Teaching Hospital Charles University, Praha, Czech Republic.
  • Lacy MQ; Clinical Department of Haematology of the First Faculty of Medicine and General Teaching Hospital, Charles University, Praha, Czech Republic.
Blood Cancer J ; 8(8): 70, 2018 07 30.
Article in En | MEDLINE | ID: mdl-30061664
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Multiple Myeloma Type of study: Diagnostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Blood Cancer J Year: 2018 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Multiple Myeloma Type of study: Diagnostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Blood Cancer J Year: 2018 Document type: Article Affiliation country: Country of publication: